Gerardus Johannes Platenburg - 18 Mar 2026 Form 3 Insider Report for ProQR Therapeutics N.V. (PRQR)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 16:08:11 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Pieter Erik de Ridders, Attorney-in-Fact

Key filing fact

Gerardus Johannes Platenburg filed Form 3 for ProQR Therapeutics N.V. (PRQR) on 18 Mar 2026.

Key facts

  • This page summarizes Gerardus Johannes Platenburg's Form 3 filing for ProQR Therapeutics N.V. (PRQR).
  • 0 reported transactions and 11 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 16:08.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002115507 Primary reporting owner

Platenburg Gerardus Johannes

Relationship
Chief Scientific Officer, Director
Address
PROQR THERAPEUTICS N.V., ZERNIKEDREEF 9, LEIDEN, NETHERLANDS
Signature
/s/ Pieter Erik de Ridders, Attorney-in-Fact
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRQR holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
824,388
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
61,453
Exercise price
$4.90
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
71,409
Exercise price
$3.30
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
17,878
Exercise price
$15.78
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
141,369
Exercise price
$9.91
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
79,033
Exercise price
$4.20
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
77,353
Exercise price
$1.02
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
172,603
Exercise price
$0.6700
Footnotes
F1
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
152,000
Exercise price
$3.41
Footnotes
F2
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
164,715
Exercise price
$1.98
Footnotes
F3
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
159,358
Exercise price
$2.65
Footnotes
F4
PRQR holding Derivative

Share Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
186,139
Exercise price
$2.02
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Fully vested.

Footnote F2

25% of the shares subject to such option vest and become exercisable on January 1, 2024, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Footnote F3

25% of the shares subject to such option vest and become exercisable on January 1, 2025, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Footnote F4

25% of the shares subject to such option vest and become exercisable on January 1, 2026, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Footnote F5

25% of the shares subject to such option vest and become exercisable on January 1, 2027, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .